A multicenter observational study of the real‐world use of docetaxel for metastatic castration‐resistant prostate cancer in China

AIM: To investigate the use of docetaxel for the treatment of metastatic castration‐resistant prostate cancer (mCRPC) in real‐world clinical practice in China. METHODS: This single‐arm, prospective, observational study was conducted at 32 study centers in China and included male patients aged ≥18 ye...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Asia Pac J Clin Oncol
Prif Awduron: He, Dalin, Sun, Zhongquan, Guo, Jianming, Zhang, Zhigen, Shan, Yuxi, Ma, Lulin, Li, Hanzhong, Jin, Jie, Huang, Yiran, Xiao, Jiaquan, Wei, Qiang, Ye, Dingwei
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850484/
https://ncbi.nlm.nih.gov/pubmed/30873737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajco.13142
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg